Ortho-substituted anthranilic acid amides and their use as medicaments
申请人:——
公开号:US20040102441A1
公开(公告)日:2004-05-27
Ortho-substituted anthranilic acid amides and use thereof as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described.
本文描述了邻位取代的蒽酸酰胺及其用途,作为治疗由持续性血管生成引发的疾病的药物。
Ortho-substituted anthranilic acid amides and their use as pharmaceutical agents
申请人:Krueger Martin
公开号:US20060014747A1
公开(公告)日:2006-01-19
Ortho-substituted anthranilic acid amides and use thereof as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis are described.
本文描述了邻位取代的蒽酸酰胺及其作为治疗由持续性血管生成引起的疾病的药物的用途。
THREE HYBRID ASSAY SYSTEM
申请人:GPC Biotech AG
公开号:EP1364212B1
公开(公告)日:2011-02-02
US7081468B2
申请人:——
公开号:US7081468B2
公开(公告)日:2006-07-25
ORTHO SUBSTITUIERTE ANTHRANILSÄUREAMIDE UND DEREN VERWENDUNG ALS ARZNEIMITTEL